Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EV/Core EBITDA

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.608.018.728.867.21

What is the latest EV/Core EBITDA ratio of BAL PHARMA ?

The latest EV/Core EBITDA ratio of BAL PHARMA is 8.60 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20258.60
Mar20248.01
Mar20238.72
Mar20228.86
Mar20217.21

How is EV/Core EBITDA of BAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 8.6
7.37
Mar2024 8.01
-8.14
Mar2023 8.72
-1.58
Mar2022 8.86
22.88
Mar2021 7.21 -

Other Financial Ratios of BAL PHARMA


Compare EV/Core EBITDA ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹106.4 Cr -1% -14.2% -19% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-1%

-14.2%

-19%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses